Cost effectiveness evaluation of a rotavirus vaccination program in Argentina.

[1]  C. Biscayart,et al.  National Immunization Commission: strengthening evidence-based decision making in Argentina. , 2014, Vaccine.

[2]  Argentina. Ministerio de Salud de la Nación,et al.  Indicadores básicos Argentina 2014 , 2014 .

[3]  R. Rheingans,et al.  Cost-effectiveness of rotavirus vaccination in Bolivia from the state perspective. , 2011, Vaccine.

[4]  M. Jit,et al.  Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world , 2011, BMC medicine.

[5]  A. Ciapponi,et al.  Burden and typing of rotavirus group A in Latin America and the Caribbean: systematic review and meta‐analysis , 2011, Reviews in medical virology.

[6]  M. C. Danovaro-Holliday,et al.  Progress in the Introduction of the Rotavirus Vaccine in Latin America and the Caribbean: Four Years of Accumulated Experience , 2011, The Pediatric infectious disease journal.

[7]  S. Allen,et al.  Probiotics for treating acute infectious diarrhoea , 2010, The Cochrane database of systematic reviews.

[8]  M. Jit,et al.  An update to "The cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe". , 2010, Vaccine.

[9]  A. Rubinstein,et al.  Economic evaluation guidelines in Latin America: a current snapshot , 2010, Expert review of pharmacoeconomics & outcomes research.

[10]  U. Parashar,et al.  Rotavirus vaccination: cost-effectiveness and impact on child mortality in developing countries. , 2009, The Journal of infectious diseases.

[11]  M. Penny,et al.  Cost-effectiveness of rotavirus vaccination in peru. , 2009, The Journal of infectious diseases.

[12]  M. Jit,et al.  The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe. , 2009, Vaccine.

[13]  G. Oster,et al.  Cost of routine immunization of young children against rotavirus infection with Rotarix versus RotaTeq. , 2009, Vaccine.

[14]  R. Rheingans,et al.  Economic impact of a rotavirus vaccination program in Mexico. , 2009, Revista panamericana de salud publica = Pan American journal of public health.

[15]  D. Bernstein,et al.  Rotarix: a rotavirus vaccine for the world. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  E. Waldman,et al.  Economic Impact of a Rotavirus Vaccine in Brazil , 2008, Journal of health, population, and nutrition.

[17]  B. Detournay,et al.  Cost-effectiveness analysis of vaccination against rotavirus with RIX4414 in France , 2008 .

[18]  Felix Espinoza,et al.  Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study , 2008, The Lancet.

[19]  Maiwenn J Al,et al.  The cost-utility of rotavirus vaccination with Rotarix (RIX4414) in the Netherlands. , 2008, Vaccine.

[20]  X. Sáez-Llorens,et al.  Impacto económico de la vacuna antirrotavirus en Panamá , 2008 .

[21]  B. Standaert,et al.  Estimating utility scores in young children with acute rotavirus gastroenteritis in the UK , 2008, Journal of medical economics.

[22]  X. Sáez-Llorens,et al.  [Economic impact of rotavirus vaccination in Panama]. , 2008, Anales de pediatria.

[23]  T. Breuer,et al.  Potential cost-effectiveness of vaccination for rotavirus gastroenteritis in eight Latin American and Caribbean countries. , 2007, Revista panamericana de salud publica = Pan American journal of public health.

[24]  R. Rheingans,et al.  [Assessment of the economic impact of the antiretroviral vaccine in Venezuela]. , 2006, Revista panamericana de salud publica = Pan American journal of public health.

[25]  R. Rheingans,et al.  [Potential cost effectiveness of a rotavirus vaccine in Chile]. , 2006, Revista medica de Chile.

[26]  T. Vesikari,et al.  Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. , 2006, The New England journal of medicine.

[27]  Mark A. Miller,et al.  Global Illness and Deaths Caused by Rotavirus Disease in Children , 2003, Emerging infectious diseases.

[28]  Á. Gentile,et al.  Epidemiologic patterns of diarrheal disease in Argentina: estimation of rotavirus disease burden , 2002, The Pediatric infectious disease journal.

[29]  J. Sachs.  Macroeconomics and health: investing in health for economic development , 2002 .

[30]  K. Bok,et al.  Surveillance for rotavirus in Argentina , 2001, Journal of medical virology.